StonvexLoading…
StonvexCore line items from BTBT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-10 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $27.64M | $27.92M | $113.56M | $81.22M | $50.76M |
Operating Income | Not available | $-142.91M | $-91.83M | $101.17M | $-40.64M |
Net Income | Not available | $-146.67M | $-80.32M | $108.05M | $-42.84M |
EPS (Diluted) | $-0.04 | $-0.45 | $-0.31 | $0.46 | $-0.22 |
Total Assets | Not available | $1.18B | $1.17B | $1.13B | $723.42M |
Total Liabilities | Not available | $572.00M | $309.16M | $87.50M | $90.23M |
Cash & Equivalents | Not available | $79.53M | $118.36M | $179.12M | $181.17M |
Free Cash Flow OCF − CapEx | Not available | $-170.26M | $-574.85M | $-368.88M | $-112.05M |
Shares Outstanding | Not available | 331.43M | 324.19M | 322.12M | 284.05M |